Shockwave Medical Inc (SWAV)
328.28
-0.26
(-0.08%)
USD |
NASDAQ |
Apr 24, 12:09
Shockwave Medical Cash from Investing (TTM): -625.73M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -625.73M |
September 30, 2023 | -418.74M |
June 30, 2023 | -118.14M |
March 31, 2023 | -28.55M |
December 31, 2022 | -62.15M |
September 30, 2022 | -49.98M |
June 30, 2022 | -49.48M |
March 31, 2022 | -28.08M |
December 31, 2021 | 26.42M |
September 30, 2021 | -104.09M |
June 30, 2021 | -87.20M |
Date | Value |
---|---|
March 31, 2021 | -84.71M |
December 31, 2020 | -107.47M |
September 30, 2020 | 62.92M |
June 30, 2020 | 58.46M |
March 31, 2020 | -54.80M |
December 31, 2019 | -59.54M |
September 30, 2019 | -77.18M |
June 30, 2019 | -85.14M |
March 31, 2019 | -2.086M |
December 31, 2018 | -0.174M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-625.73M
Minimum
Dec 2023
62.92M
Maximum
Sep 2020
-99.64M
Average
-62.15M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
Boston Scientific Corp | -2.574B |
AtriCure Inc | 21.82M |
Masimo Corp | -81.20M |
Perspective Therapeutics Inc | 24.37M |
Xtant Medical Holdings Inc | -24.78M |